NEUVOGEN
NEUVOGEN is applying a systems biology approach to develop whole-cell therapeutic cancer vaccines.
NEUVOGEN
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.neuvogen.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
CisThera
CisThera is a private biopharmaceutical company that is developing novel therapeutics for cancer and autoimmune diseases.
ORGANIC GENOMICS
ORGANIC GENOMICS is a biotechnology company for developing health care products of therapeutic proteins.
Current Employees Featured
Official Site Inspections
http://www.neuvogen.com Semrush global rank: 5.8 M Semrush visits lastest month: 1.44 K
- Host name: 13.82.129.126
- IP address: 13.82.129.126
- Location: Washington United States
- Latitude: 38.7095
- Longitude: -78.1539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 22747
More informations about "NEUVOGEN"
NEUVOGEN – NEUVOGEN is an immunoncology company …
NEUVOGEN is an immuno-oncology company applying a systems approach to develop therapeutic whole cell cancer vaccines to transform how cancer is treated. The NEUVOGEN …See details»
ABOUT US - NEUVOGEN
NEUVOGEN is an immuno-oncology company applying a systems biology approach to develop the next generation of whole cell therapeutic cancer vaccines designed to improve and prolong …See details»
NEUVOGEN - Crunchbase Company Profile & Funding
NEUVOGEN is applying a systems biology approach to develop whole-cell therapeutic cancer vaccines. View contacts for NEUVOGEN to access new leads and connect with decision-makers.See details»
NEUVOGEN, Inc. - LinkedIn
NEUVOGEN is an immunoncology company applying a systems approach to develop therapeutic whole cell cancer vaccines to transform how cancer is treated. Our mission is to serve patients …See details»
OUR SCIENCE - NEUVOGEN
In order to drive the deepest and most durable clinical response, NEUVOGEN’s proprietary platform is designed to theoretically target all the cancer cells within a tumor, and then amplify …See details»
Neuvogen Company Profile 2024: Valuation, Funding & Investors
Developer of therapeutic vaccines designed for cancer treatment by harnessing the full power of a patient's immune system. The company is applying a systems approach to develop medicinal …See details»
Todd Binder - CEO & Board Member at NEUVOGEN - The Org
Mr. Todd Binder is Chief Executive Officer and member of the Board of Directors of NEUVOGEN, and leads the company’s overall strategy to serve patients through the development of …See details»
Neuvogen - VentureRadar
NEUVOGEN is an immunoncology company applying a systems approach to develop therapeutic whole cell cancer vaccines to transform how cancer is treated. The NEUVOGEN platform …See details»
Mark Bagarazzi - Chief Medical Officer at NEUVOGEN | The Org
Dr. Mark Bagarazzi is Chief Medical Officer at NEUVOGEN where he is responsible for providing leadership and setting the overall strategic direction for the research and clinical development …See details»
NEUVOGEN Appoints Stephen A. Sherwin, M.D. to its ... - PR …
Jul 25, 2022 · Based in San Diego, California, NEUVOGEN's goal is to develop therapeutic cancer vaccines that activate the body's immune system to eradicate solid tumors and …See details»
Neuvogen - Overview, News & Similar companies | ZoomInfo.com
Apr 11, 2022 · View Neuvogen (www.neuvogen.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
PIPELINE – NEUVOGEN
NEUVOGEN is advancing a broad pipeline of therapeutic whole cell cancer vaccine candidates designed to activate the patient’s immune system to target and eliminate existing tumors and …See details»
Neuvogen, Inc. Company Profile | San Diego, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Neuvogen, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
George Montgomery - CFO at NEUVOGEN | The Org
Mr. George Montgomery has more than three decades of experience raising capital and providing strategic advisory to entrepreneurial biotech and medical technology companies. He has …See details»
NEUVOGEN Announces Next Generation Cancer Vaccine Strategy …
SAN DIEGO, Jan. 20, 2021 /PRNewswire/ -- NEUVOGEN, an immunoncology company, announces its novel cancer vaccine strategy to transform how solid tumors are treated. …See details»
NEUVOGEN Appoints Stephen A. Sherwin, M.D. to its Scientific …
San Diego CA/July 25, 2022: NEUVOGEN, an immuno-oncology company with a next-generation cancer vaccine platform, is pleased to announce the appointment of Stephen A. Sherwin, …See details»
NEUVOGEN Announces Next Generation Cancer Vaccine Strategy …
SAN DIEGO, Jan. 20, 2021 /PRNewswire/ -- NEUVOGEN, an immunoncology company, announces its novel cancer vaccine strategy to transform how solid tumors are treated. …See details»
NEUVOGEN Announces Appointment of Chief Financial Officer
San Diego CA/December 21, 2021: NEUVOGEN, an immunoncology company, is pleased to announce the appointment of George Montgomery as Chief Financial Officer. He will oversee …See details»
Neuvogen | VentureRadar
Similar Companies: Bilthoven Biologicals Netherlands n/a Bilthoven Biologicals is a biopharmaceutical company which produces Inactivated Polio Vaccines (IPV), Tetanus …See details»
NEWS – NEUVOGEN
Jan 25, 2021 · July 25, 2022 – NEUVOGEN Appoints Stephen A. Sherwin, M.D. to its Scientific Advisory Board. April 11, 2022 – NEUVOGEN Appoints Vaccine Manufacturing expert, Peter …See details»